MedTrace Logo

Trial of Mongolian Medicine ZhenBao Pills for Upper-limb Dysfunction After Stroke

NCT06049498 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2023-09-22

No results posted yet for this study

Summary

The trial was designed to test the hypothesis that treatment with Mongolian Medicine ZhenBao Pills has a positive effect on upper-limb motor recovery after acute ischemic stroke.

Conditions

Interventions

DRUG

Mongolian Medicine ZhenBao Pills

Mongolian Medicine ZhenBao Pills, orally, 15 pills each time, twice a day.

DRUG

Mongolian Medicine ZhenBao Pills Placebo

Mongolian Medicine ZhenBao Pills placebo, orally, 15 pills each time, twice a day.

Sponsors & Collaborators

  • Dongzhimen Hospital, Beijing

    lead OTHER

Principal Investigators

  • Ying Gao, MD · Dongzhimen Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2025-10-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06049498 on ClinicalTrials.gov